Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SX3P
Consumer Staples
SX3P
Consumer Staples
SX3P
+0.58%
619.21
+3.56
+0.58%
—615.65615.07619.70614.21——
SX6P
Utilities
SX6P
Utilities
SX6P
-3.70%
530.86
-20.38
-3.70%
—551.24548.70548.70530.09——
SX8P
Technology
SX8P
Technology
SX8P
-1.74%
930.62
-16.46
-1.74%
—947.08946.19946.19917.62——
SXAP
Consumer Discretionary
SXAP
Consumer Discretionary
SXAP
-1.87%
456.05
-8.70
-1.87%
—464.75463.99464.64453.17——
SXDP
Health Care
SXDP
Health Care
SXDP
-0.35%
1,090.63
-3.82
-0.35%
—1,094.451,093.531,102.341,089.23——
SXEP
Energy
SXEP
Energy
SXEP
-0.14%
535.34
-0.73
-0.14%
—536.07535.49537.10532.16——
SXFP
Financials
SXFP
Financials
SXFP
-0.53%
890.23
-4.73
-0.53%
—894.96895.33896.45886.07——
SXKP
Communications
SXKP
Communications
SXKP
-1.11%
312.78
-3.52
-1.11%
—316.30317.30317.88312.06——
SXNP
Industrials
SXNP
Industrials
SXNP
-2.47%
1,095.60
-27.75
-2.47%
—1,123.351,118.991,118.991,092.58——
SXPP
Materials
SXPP
Materials
SXPP
-5.11%
818.07
-44.02
-5.11%
—862.09841.63841.63810.46——
Q1 2026 earnings • released • EPS miss -12.84%
See results
IMUX:NASDAQ
Immunic Inc
$12.08
-4.54%
(-0.57) 1D
$12.12
+0.33% (+0.040)
After hours
Closed: May 15, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IMUX...
Open
$12.36
High
$12.57
Low
$11.65
Mkt. cap
164.48M
Avg. vol.
314.75K
Volume
161.74K
52-wk high
$15.10
52-wk low
$5.06
EPS
-$5.42
Beta
1.20
Shares outstanding
13.62M
No. of employees
92
News stories
From sources across the web
About Immunic Inc
CEODaniel Vitt
Employees92
FoundedMay 2003
Headquarters-
SectorBiotechnology
Websiteimux.com
Last report
May 13, 2026
Fiscal Period
Q1 2026
EPS / Est. (USD)
-$1.08 / -$0.96
-12.84%miss
Revenue / Est. (USD)
- / 0.00
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
21.37M
20.01M
19.07M
25.63M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.71M
5.98M
4.26M
7.61M
Operating expense
27.08M
25.99M
23.33M
33.24M
Total operating expenses
27.08M
25.99M
23.33M
33.24M
Operating income
-27.08M
-25.99M
-23.33M
-33.24M
Other non operating income
22.00K
-5.00K
5.53M
-113.00K
EBT including unusual items
-26.82M
-25.58M
-19.30M
-32.59M
EBT excluding unusual items
-26.82M
-25.58M
-17.60M
-32.59M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-26.82M
-25.58M
-19.30M
-32.59M
Net profit margin
-
-
-
-
Earnings per share
-2.00
-1.30
-0.70
-1.08
Interest and investment income
241.00K
419.00K
197.00K
760.00K
Interest expense
-
-
-
-
Net interest expenses
241.00K
419.00K
197.00K
760.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-27.04M
-25.95M
-23.28M
-33.20M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer